J.E. Ang

449 total citations
7 papers, 348 citations indexed

About

J.E. Ang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, J.E. Ang has authored 7 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in J.E. Ang's work include HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). J.E. Ang is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). J.E. Ang collaborates with scholars based in United Kingdom, United States and Germany. J.E. Ang's co-authors include Timothy A. Yap, Johann S. de Bono, James Spicer, Martina Uttenreuther‐Fischer, Mehdi Shahidi, Ruth Plummer, Susan Bell, Laura Vidal, Graham Temple and P. Andrew Futreal and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

J.E. Ang

7 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.E. Ang United Kingdom	4	262	235	142	36	34	7	348
Sonia Garofalo Italy	6	189 0.7×	126 0.5×	145 1.0×	27 0.8×	30 0.9×	7	364
Cath Trigwell United Kingdom	6	150 0.6×	136 0.6×	220 1.5×	41 1.1×	42 1.2×	9	365
Keita Masuzawa Japan	10	239 0.9×	285 1.2×	190 1.3×	30 0.8×	19 0.6×	24	418
Maria S. Romero Spain	5	297 1.1×	266 1.1×	235 1.7×	30 0.8×	48 1.4×	6	497
Mariangela Zanghì Italy	7	234 0.9×	211 0.9×	144 1.0×	34 0.9×	40 1.2×	12	414
Geetha D. Vallabhaneni United States	4	274 1.0×	262 1.1×	275 1.9×	11 0.3×	26 0.8×	4	532
Leticia Tetteh United States	6	306 1.2×	112 0.5×	197 1.4×	21 0.6×	11 0.3×	11	456
Christa L. Borgman United States	5	126 0.5×	118 0.5×	203 1.4×	17 0.5×	62 1.8×	5	325
Kim-Son H. Nguyen United States	4	265 1.0×	295 1.3×	203 1.4×	23 0.6×	22 0.6×	7	432
Eric D. Mininberg United States	3	345 1.3×	307 1.3×	192 1.4×	16 0.4×	27 0.8×	6	494

Countries citing papers authored by J.E. Ang

Since Specialization

Citations

This map shows the geographic impact of J.E. Ang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.E. Ang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.E. Ang more than expected).

Fields of papers citing papers by J.E. Ang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.E. Ang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.E. Ang. The network helps show where J.E. Ang may publish in the future.

Co-authorship network of co-authors of J.E. Ang

This figure shows the co-authorship network connecting the top 25 collaborators of J.E. Ang. A scholar is included among the top collaborators of J.E. Ang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.E. Ang. J.E. Ang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Ang, J.E., S. Gaillard, Hsin‐An Chen, et al.. (2024). 791P Activity of ERK1/2 inhibitor ASTX029 in patients with gynecological malignancies harboring genomic alterations in the MAPK pathway. Annals of Oncology. 35. S591–S591. 1 indexed citations

2.

Suder, Aneta, J.E. Ang, Sarah Rudman, et al.. (2015). A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours. European Journal of Cancer. 51(16). 2275–2284. 22 indexed citations

3.

Tan, David S.P., Timothy A. Yap, Margaret Hutka, et al.. (2012). Implications of BRCA1 and BRCA2 mutations for the efficacy of paclitaxel monotherapy in advanced ovarian cancer. European Journal of Cancer. 49(6). 1246–1253. 23 indexed citations

4.

Yap, Timothy A., Laura Vidal, Jan Adam, et al.. (2010). Phase I Trial of the Irreversible EGFR and HER2 Kinase Inhibitor BIBW 2992 in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 28(25). 3965–3972. 295 indexed citations

5.

Kristeleit, Rebecca, Martin Förster, J.E. Ang, et al.. (2009). Activity of BIBW 2992, an oral irreversible EGFR/HER2 dual kinase inhibitor, in combination with weekly paclitaxel in non-small cell lung cancer. Journal of Thoracic Oncology. 4(9). 4 indexed citations

6.

Ang, J.E., et al.. (2008). 393 POSTER First-in-man Phase I trial of BYK408740, an oral histone deacetylase inhibitor, in patients with advanced malignancies. European Journal of Cancer Supplements. 6(12). 123–124. 1 indexed citations

7.

Molife, R., James Lee, Daniel Petrylak, et al.. (2007). A phase I study of oral belinostat (PXD101) in patients with advanced solid tumors.. Molecular Cancer Therapeutics. 6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact